T. Rowe Price Associates’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $52K | Hold |
|
|||||
|
2024
Q4 | $47K | Sell |
|
|||||
|
2024
Q3 | $3.38M | Buy |
|
|||||
|
2024
Q2 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $55K | Hold |
|
|||||
|
2021
Q4 | $58K | Buy |
|
|||||
|
2021
Q3 | $26K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $257K | Hold |
|
|||||
|
2016
Q3 | $378K | Buy |
|
|||||
|
2016
Q2 | $305K | Sell |
|
|||||
|
2016
Q1 | $744K | Sell |
|
|||||
|
2015
Q4 | $1.09M | Buy |
|
|||||
|
2015
Q3 | $783K | Buy |
|
|||||
|
2015
Q2 | $1.29M | Buy |
|
|||||
|
2015
Q1 | $1.65M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $2.31M | Buy |
|
|||||
|
2014
Q2 | $2.71M | Buy |
|
|||||
|
2014
Q1 | $3.04M | Sell |
|
|||||
|
2013
Q4 | $2.51M | Buy |
|
|||||
|
2013
Q3 | $2.51M | Buy |
|